BioCentury
ARTICLE | Company News

Gottlieb rebukes Nostrum’s 300% price hike for generic antibiotic

September 11, 2018 11:55 PM UTC

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Tuesday.

Gottlieb said in a tweet that FDA will promote competition to nullify attempts by companies such as Nostrum "to take advantage of patients who need medicine." ...